Market Currents
Life Technologies (LIFE +1%) trades higher after receiving FDA clearance for its OpTmizer T-Cell...
-
Thursday, September 27, 2012, 3:25 PM ETLife Technologies (LIFE +1%) trades higher after receiving FDA clearance for its OpTmizer T-Cell growth medium for use in clinical trials. The product is designed to efficiently grow large numbers of potentially therapeutic T-cells, which have demonstrated promise in clinical studies as an effective treatment for diseases including cancer, infectious diseases such as AIDS, and autoimmune disorders.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
